Possible involvement of EBV-mediated α-fodrin cleavage for organ-specific autoantigen in Sjogren's syndrome

被引:40
作者
Inoue, H
Tsubota, K
Ono, M
Kizu, Y
Mizuno, F
Takada, K
Yamada, K
Yanagi, K
Hayashi, Y
Saito, I
机构
[1] Univ Tokushima, Sch Dent, Dept Pathol, Tokushima 7708504, Japan
[2] Tokyo Dent Coll, Dept Ophthalmol, Chiba, Japan
[3] Tokyo Dent Coll, Dept Oral Med, Chiba, Japan
[4] Tokyo Med Univ, Dept Microbiol, Tokyo, Japan
[5] Hokkaido Univ, Sch Med, Inst Canc, Dept Virol, Sapporo, Hokkaido 060, Japan
关键词
D O I
10.4049/jimmunol.166.9.5801
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A cleavage product of alpha -fodrin may be an important organ-specific autoantigen in the pathogenesis of Sjogren's syndrome (SS), but the mechanisms of alpha -fodrin cleavage remain unclear. Since EBV has been implicated in the pathogenesis of SS, we determined whether EBV activation could induce the SS-specific 120-kDa autoantigen alpha -fodrin. ZEBRA mRNA expression, a marker for activation of the lytic cycle of EBV, was found in the salivary gland tissues from SS patients, but not in those from control individuals. ZEBRA-expressing lymphoid cells were also found in the SS glands in double-stained immunohistochemistry. Furthermore, a significant link between production of Abs against 120-kDa alpha -fodrin and reactivated EBV Ag was found in sera from patients with SS, but not in those from control individuals. EBV-activated lymphoid cells showed specific alpha -fodrin cleavage to the expected 120-kDa fragments in vitro. Pretreatment with caspase inhibitors inhibited cleavage of alpha -fodrin. Thus, an increase in apoptotic protease activities induced by EBV reactivation may be involved in the progression of alpha -fodrin proteolysis in the development of SS.
引用
收藏
页码:5801 / 5809
页数:9
相关论文
共 72 条
[41]   POSSIBLE INVOLVEMENT OF EPSTEIN-BARR VIRUS (EBV) IN POLYCLONAL B-CELL ACTIVATION IN SJOGRENS SYNDROME [J].
MIYASAKA, N ;
YAMAOKA, K ;
TATEISHI, M ;
NISHIOKA, K ;
YAMAMOTO, K .
JOURNAL OF AUTOIMMUNITY, 1989, 2 (04) :427-432
[42]  
MORGAN DG, 1979, LANCET, V2, P1154
[43]   GENETIC-DIFFERENCES BETWEEN PRIMARY AND SECONDARY SICCA SYNDROME [J].
MOUTSOPOULOS, HM ;
MANN, DL ;
JOHNSON, AH ;
CHUSED, TM .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (14) :761-763
[44]   THE TARGET-CELL NUCLEUS IS NOT REQUIRED FOR CELL-MEDIATED GRANZYME-BASED OR FAS-BASED CYTOTOXICITY [J].
NAKAJIMA, H ;
GOLSTEIN, P ;
HENKART, PA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1905-1909
[45]   Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: Contributory roles of both protease families in neuronal apoptosis [J].
Nath, R ;
Raser, KJ ;
Stafford, D ;
Hajimohammadreza, I ;
Posner, A ;
Allen, H ;
Talanian, RV ;
Yuen, PW ;
Gilbertsen, RB ;
Wang, KKW .
BIOCHEMICAL JOURNAL, 1996, 319 :683-690
[46]   IDENTIFICATION AND INHIBITION OF THE ICE/CED-3 PROTEASE NECESSARY FOR MAMMALIAN APOPTOSIS [J].
NICHOLSON, DW ;
ALI, A ;
THORNBERRY, NA ;
VAILLANCOURT, JP ;
DING, CK ;
GALLANT, M ;
GAREAU, Y ;
GRIFFIN, PR ;
LABELLE, M ;
LAZEBNIK, YA ;
MUNDAY, NA ;
RAJU, SM ;
SMULSON, ME ;
YAMIN, TT ;
YU, VL ;
MILLER, DK .
NATURE, 1995, 376 (6535) :37-43
[47]   Cytokine messenger RNA expression in the labial salivary glands of patients with Sjogren's syndrome [J].
Ohyama, Y ;
Nakamura, S ;
Matsuzaki, G ;
Shinohara, M ;
Hiroki, A ;
Fujimura, T ;
Yamada, A ;
Itoh, K ;
Nomoto, K .
ARTHRITIS AND RHEUMATISM, 1996, 39 (08) :1376-1384
[48]  
PARRY SL, 1994, J IMMUNOL, V152, P2821
[49]  
PEPOSE JS, 1990, OPHTHALMOLOGY, V97, P1599
[50]  
RICKINSON AB, 1981, CANCER RES, V41, P4216